Connection

Dennis Watson to Humans

This is a "connection" page, showing publications Dennis Watson has written about Humans.
Connection Strength

0.480
  1. Preface. Adv Cancer Res. 2017; 133:ix-xi.
    View in: PubMed
    Score: 0.021
  2. FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression. Neoplasia. 2014 Oct; 16(10):801-13.
    View in: PubMed
    Score: 0.018
  3. Understanding the role of ETS-mediated gene regulation in complex biological processes. Adv Cancer Res. 2013; 119:1-61.
    View in: PubMed
    Score: 0.016
  4. Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia. Blood. 2011 Nov 17; 118(20):5604-12.
    View in: PubMed
    Score: 0.015
  5. Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression. Prostate. 2011 Dec; 71(16):1723-35.
    View in: PubMed
    Score: 0.014
  6. Slug expression enhances tumor formation in a noninvasive rectal cancer model. J Surg Res. 2011 Sep; 170(1):56-63.
    View in: PubMed
    Score: 0.014
  7. Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1. Mol Cell Biol. 2010 Nov; 30(21):5194-206.
    View in: PubMed
    Score: 0.014
  8. Hematopoietic stem cell origin of connective tissues. Exp Hematol. 2010 Jul; 38(7):540-7.
    View in: PubMed
    Score: 0.013
  9. Hematopoietic stem cell origin of mesenchymal cells: opportunity for novel therapeutic approaches. Int J Hematol. 2010 Apr; 91(3):353-9.
    View in: PubMed
    Score: 0.013
  10. PDEF is a negative regulator of colon cancer cell growth and migration. J Cell Biochem. 2009 Dec 15; 108(6):1389-98.
    View in: PubMed
    Score: 0.013
  11. MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. Cancer Res. 2008 Oct 15; 68(20):8499-506.
    View in: PubMed
    Score: 0.012
  12. Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. Mol Biol Cell. 2008 Sep; 19(9):3745-57.
    View in: PubMed
    Score: 0.012
  13. Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis. Cancer Res. 2008 Jun 01; 68(11):4097-104.
    View in: PubMed
    Score: 0.012
  14. ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Rev Anticancer Ther. 2008 Jan; 8(1):33-42.
    View in: PubMed
    Score: 0.011
  15. Defining ETS transcription regulatory networks and their contribution to breast cancer progression. J Cell Biochem. 2007 Oct 15; 102(3):549-59.
    View in: PubMed
    Score: 0.011
  16. Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. Cancer Res. 2007 Feb 15; 67(4):1618-25.
    View in: PubMed
    Score: 0.011
  17. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer. J Urol. 2006 Jun; 175(6):2312-6.
    View in: PubMed
    Score: 0.010
  18. Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. Cancer Res. 2005 Dec 15; 65(24):11581-7.
    View in: PubMed
    Score: 0.010
  19. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer. 2005 Nov; 41(16):2462-78.
    View in: PubMed
    Score: 0.010
  20. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability. Cancer Res. 2005 Jul 15; 65(14):6228-36.
    View in: PubMed
    Score: 0.010
  21. The FLI-1 transcription factor is a short-lived phosphoprotein in T cells. J Biochem. 2005 Mar; 137(3):297-302.
    View in: PubMed
    Score: 0.009
  22. SP100 inhibits ETS1 activity in primary endothelial cells. Oncogene. 2005 Jan 27; 24(5):916-31.
    View in: PubMed
    Score: 0.009
  23. Ets-dependent regulation of target gene expression during megakaryopoiesis. J Biol Chem. 2004 Dec 10; 279(50):52183-90.
    View in: PubMed
    Score: 0.009
  24. SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion. Oncogene. 2004 Aug 26; 23(39):6654-65.
    View in: PubMed
    Score: 0.009
  25. Ets proteins in biological control and cancer. J Cell Biochem. 2004 Apr 01; 91(5):896-903.
    View in: PubMed
    Score: 0.009
  26. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res. 2003 Aug 01; 63(15):4626-31.
    View in: PubMed
    Score: 0.008
  27. Marker-assisted study of genetic background and gene-targeted locus modifiers in lymphopoietic phenotypes. Anticancer Res. 2003 May-Jun; 23(3A):2015-26.
    View in: PubMed
    Score: 0.008
  28. The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesis. Anticancer Res. 2003 May-Jun; 23(3A):2125-31.
    View in: PubMed
    Score: 0.008
  29. Regulation of Ets function by protein - protein interactions. Oncogene. 2000 Dec 18; 19(55):6514-23.
    View in: PubMed
    Score: 0.007
  30. Ets target genes: past, present and future. Oncogene. 2000 Dec 18; 19(55):6533-48.
    View in: PubMed
    Score: 0.007
  31. ETS2 function is required to maintain the transformed state of human prostate cancer cells. Oncogene. 1998 Dec 03; 17(22):2883-8.
    View in: PubMed
    Score: 0.006
  32. Functional relationships among ETS gene family members. Leukemia. 1997 Apr; 11 Suppl 3:557-66.
    View in: PubMed
    Score: 0.005
  33. Complementary feature selection from alternative splicing events and gene expression for phenotype prediction. Bioinformatics. 2016 09 01; 32(17):i421-i429.
    View in: PubMed
    Score: 0.005
  34. Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA. BMC Genomics. 2016 Mar 31; 17:263.
    View in: PubMed
    Score: 0.005
  35. Essential Components of Cancer Education. Cancer Res. 2015 Dec 15; 75(24):5202-5.
    View in: PubMed
    Score: 0.005
  36. Generation and characterization of monoclonal antibodies against the ERGB/FLI-1 transcription factor. Hybridoma. 1995 Dec; 14(6):563-9.
    View in: PubMed
    Score: 0.005
  37. Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironment. Neoplasia. 2015 May; 17(5):434-48.
    View in: PubMed
    Score: 0.005
  38. SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression. Mol Cancer Ther. 2014 Nov; 13(11):2713-26.
    View in: PubMed
    Score: 0.005
  39. Fli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activation. Mol Immunol. 2015 Feb; 63(2):566-73.
    View in: PubMed
    Score: 0.005
  40. Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancer. Mol Carcinog. 2014 Feb; 53 Suppl 1:E130-9.
    View in: PubMed
    Score: 0.004
  41. Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection. J Virol. 2013 Jan; 87(1):621-35.
    View in: PubMed
    Score: 0.004
  42. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth Differ. 1992 Oct; 3(10):705-13.
    View in: PubMed
    Score: 0.004
  43. Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney. Clin Immunol. 2012 Dec; 145(3):201-8.
    View in: PubMed
    Score: 0.004
  44. Loss of expression and function of SOCS3 is an early event in HNSCC: altered subcellular localization as a possible mechanism involved in proliferation, migration and invasion. PLoS One. 2012; 7(9):e45197.
    View in: PubMed
    Score: 0.004
  45. Urinary thromboxane B2 and thromboxane receptors in bladder cancer: opportunity for detection and monitoring. Prostaglandins Other Lipid Mediat. 2011 Nov; 96(1-4):41-4.
    View in: PubMed
    Score: 0.004
  46. Molecular organization and differential polyadenylation sites of the human ETS2 gene. Oncogene. 1990 Oct; 5(10):1521-7.
    View in: PubMed
    Score: 0.003
  47. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am J Pathol. 2010 Apr; 176(4):1983-98.
    View in: PubMed
    Score: 0.003
  48. Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression. J Biol Chem. 2010 Apr 09; 285(15):11258-69.
    View in: PubMed
    Score: 0.003
  49. Molecular analysis of the ets genes and their products. Crit Rev Oncog. 1990; 1(4):409-36.
    View in: PubMed
    Score: 0.003
  50. Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemia. Exp Hematol. 2009 Dec; 37(12):1464-71.
    View in: PubMed
    Score: 0.003
  51. Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage. Proc Natl Acad Sci U S A. 2009 Aug 18; 106(33):13814-9.
    View in: PubMed
    Score: 0.003
  52. Mammalian ets-1 and ets-2 genes encode highly conserved proteins. Proc Natl Acad Sci U S A. 1988 Nov; 85(21):7862-6.
    View in: PubMed
    Score: 0.003
  53. CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes. Am J Respir Cell Mol Biol. 2008 Jun; 38(6):671-8.
    View in: PubMed
    Score: 0.003
  54. Caspase-1 is a direct target gene of ETS1 and plays a role in ETS1-induced apoptosis. Cancer Res. 2005 Aug 15; 65(16):7205-13.
    View in: PubMed
    Score: 0.002
  55. Developmental expression pattern of D-ets4, the Drosophila homologue of human Pdef. Gene Expr Patterns. 2004 Dec; 5(2):285-9.
    View in: PubMed
    Score: 0.002
  56. Interleukins 2 and 15 regulate Ets1 expression via ERK1/2 and MNK1 in human natural killer cells. J Biol Chem. 2005 Feb 11; 280(6):4772-8.
    View in: PubMed
    Score: 0.002
  57. Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells. Nucleic Acids Res. 2004; 32(14):4358-67.
    View in: PubMed
    Score: 0.002
  58. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol. 2003 Aug; 163(2):571-81.
    View in: PubMed
    Score: 0.002
  59. Nucleotide sequence analysis of human c-myc locus, chicken homologue, and myelocytomatosis virus MC29 transforming gene reveals a highly conserved gene product. Proc Natl Acad Sci U S A. 1983 Jun; 80(12):3642-5.
    View in: PubMed
    Score: 0.002
  60. EAPII interacts with ETS1 and modulates its transcriptional function. Oncogene. 2003 May 08; 22(18):2699-709.
    View in: PubMed
    Score: 0.002
  61. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer. Int J Oncol. 2003 May; 22(5):1033-43.
    View in: PubMed
    Score: 0.002
  62. CaSm antisense gene therapy: a novel approach for the treatment of pancreatic cancer. Anticancer Res. 2003 May-Jun; 23(3A):2007-13.
    View in: PubMed
    Score: 0.002
  63. Ets1 is an effector of the transforming growth factor beta (TGF-beta ) signaling pathway and an antagonist of the profibrotic effects of TGF-beta. J Biol Chem. 2002 Jun 07; 277(23):20399-408.
    View in: PubMed
    Score: 0.002
  64. Defects of DNA mismatch repair in human prostate cancer. Cancer Res. 2001 May 15; 61(10):4112-21.
    View in: PubMed
    Score: 0.002
  65. Increased expression of the ETS-related transcription factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype. Cell Growth Differ. 1996 Nov; 7(11):1525-34.
    View in: PubMed
    Score: 0.001
  66. ETS family proteins activate transcription from HIV-1 long terminal repeat. AIDS Res Hum Retroviruses. 1993 Oct; 9(10):1017-23.
    View in: PubMed
    Score: 0.001
  67. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody. Oncogene. 1993 Jul; 8(7):1783-90.
    View in: PubMed
    Score: 0.001
  68. Genomic dispersal of the ets gene family during metazoan evolution. Oncogene. 1992 Sep; 7(9):1713-9.
    View in: PubMed
    Score: 0.001
  69. The human ETS1 gene: genomic structure, promoter characterization and alternative splicing. Oncogene. 1991 Apr; 6(4):523-32.
    View in: PubMed
    Score: 0.001
  70. The human ETS-2 gene promoter: molecular dissection and nuclease hypersensitivity. Oncogene. 1990 Sep; 5(9):1337-42.
    View in: PubMed
    Score: 0.001
  71. Molecular and functional characterization of the promoter of ETS2, the human c-ets-2 gene. Proc Natl Acad Sci U S A. 1990 Feb; 87(3):1047-51.
    View in: PubMed
    Score: 0.001
  72. ETS family of genes in leukemia and Down syndrome. Am J Med Genet Suppl. 1990; 7:251-61.
    View in: PubMed
    Score: 0.001
  73. The ETS family of genes: structural analysis, gene products, and involvement in neoplasia and other pathologies. Prog Clin Biol Res. 1990; 360:137-68.
    View in: PubMed
    Score: 0.001
  74. c-ets-2 protooncogene has mitogenic and oncogenic activity. Proc Natl Acad Sci U S A. 1989 Oct; 86(20):7833-7.
    View in: PubMed
    Score: 0.001
  75. Expression of human and viral ets genes in E. coli production of human ets-2-specific monoclonal antibodies. Oncogene Res. 1989; 5(1):61-6.
    View in: PubMed
    Score: 0.001
  76. Viral myc genes and their cellular homologs. Gene Amplif Anal. 1986; 4:109-42.
    View in: PubMed
    Score: 0.001
  77. Molecular evolution of ets genes from avians to mammals and their cytogenetic localization to regions involved in leukemia. Gene Amplif Anal. 1986; 4:207-38.
    View in: PubMed
    Score: 0.001
  78. Oncogenes: molecular probes for clinical application in malignant diseases. Gene Amplif Anal. 1986; 4:253-77.
    View in: PubMed
    Score: 0.001
  79. Two oncogenes in avian carcinoma virus MH2: myc and mht. Anticancer Res. 1985 Jan-Feb; 5(1):73-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.